New in vitro preclinical data show CLN-978 induced similar T cell activation, target B cell depletion, and cytokine ...

Werewolf Therapeutics ( (HOWL) ) just unveiled an update. Werewolf Therapeutics is pioneering the development of innovative cytokine therapies ...

In ex vivo primary cell models, the authors demonstrated that p300 KAT inhibition by KB-7898 modulated proinflammatory ...

Infectious and non-infectious respiratory diseases are regarded as accelerated-age conditions in which chronic inflammation, exacerbated/dysregulated immune responses, and immunological senescence ...

As of September 30, 2024, Fortress' consolidated cash and cash equivalents totaled $58.9 million, compared to $76.2 million ...

Real-world results may differ from those seen in clinical trials for CAR T-cell therapy and bispecific antibodies for the ...

Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

At a recent Community Case Forum, an expert discussed the risk of cytokine release syndrome after patients undergo CAR T-cell ...

There are some challenges of CAR T cell therapy, which are as follows: CAR T cell therapy can have significant side effects, ...

All patients experienced treatment-emergent adverse events, Adaptimmune said. The most common adverse events were cytopenias, ...